Published in Gene Therapy Weekly, July 13th, 2006
Study 1: Activations of c-fos/c-jun signaling are involved in the modulation of fo hypothalamic superoxide dismutase (SOD) and neuropeptide Y (NPY) gene expression in amphetamine (AMPH)-mediated appetite suppression.
"AMPH is known as an anorectic agent. The mechanism underlying the anorectic action of AMPH has been attributed to its inhibitory action on hypothalamic NPY, an appetite stimulant in the brain. This study was aimed to examine the molecular mechanisms behind the anorectic effect of AMPH," wrote Y.S. Hsieh and colleagues, Chung Shan Medical...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.